Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance[v3] Preprints.org The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA to weigh easing limits on peptides promoted by RFK Jr. NBC 6 South Florida The Unregulated World of Peptides: A Legal Minefield for Providers Holt Law Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance Sports Medicine Springer Nature Link FDA Is Expected to Lift Restriction on Peptides, Heeding RFK Jr.'s Wishes The New York Times